BNTX looks to be completing a primary B wave retracement to begin the bio bear market. Target $167. Not advice.
BNTX Price finds support at monthly pivot S1 line and daily inside bar has been formed. Close above 150.3$ triggers idea with profit target 187$ and stop 145$. Risk Reward ratio 7.0
Angry bear has mad a weapon integrating three powerful and heavy elements and waiting for the stock to hammer it down ! Long term down trend line , 200 days moving average and lost golden ratio Retracement level are the elements of the bear's weapon. Can BNTX make a heroic attack and defeat the angry bear? Not without a powerful comparable weapon I think. It...
BNTX will pop-up on next earnings day. Technicals suggest the stock has been building a bottom the last couple of months. Now is well above the 50 day EMA and it is begining to challenge the 200 day EMA. The P/E ratio and Forward P/E ratio are in the low single digits. I expanded my position when BNTX crossed above the 50 day EMA.
Buy Above $ 170 TGT- 180 TGT-2- 186 SL 159 Sell Below 159 TGT- 153 TGT-2 149 SL 165
BNTX is finally concluding a year long descending triangle pattern. I see a low risk entry at $150 and will be buying. Stop loss set at $138.49, risking about 8.5%. If we see a large move upward, I could see the stock retesting both its 200 day moving average (likely at $183) and its next major resistance after that at $295. A potential of nearly 100% profit (not...
$BNTX Breakout in 1h Chart 1. Positive Super Trend in 4h Chart & Consolidation > 8 days 2. Several touching points with vwap 3. Price above 10, 20 & 50 EMA 4. Target 205$ 5. Stop-Loss 164$ 6. Risk Reward Ratio 11.3
The PEAD projected a Bullish outlook for $BNTX after a Positive Under reaction following its earnings release placing the stock in drift A.
The Statistics say between $182-$253 (1 year) This Looks like it can Happen in 1 Year. That will depend on their Progress. Let's see what will happen in 2023, but it looks ok to hold for the next 5 Years or more BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention with the initiation of a clinical trial by end of 2022 BioNTech is...
Entering here for a possible inv h&s continuation targeting 240. (1.618 fib level). Stop loss @120. Should be a good spot to take profits and leave half running.
$bntx has NO volume support until green box 24% lower... #bntx —————————————————————————————— Top 10 trading tips: 1. DO NOT FOMO into a trade. Let it come to you. Don’t force it. 2. Find a strategy that works for you and be consistent. Operate like a machine and less like the wind. 3. Let your winners run and cut your losers short. 4. You will not win every...
Swing Idea For 4/7 under 159 145-148 possible #options #optionstrading
BioNTech Q4 December 21' earnings are on 3/30 pre-market 6:45am. BioNTech Se ADR (BNTX) reported Q3 September 2021 earnings of $14.56 per share on revenue of $7.2 billion. The consensus earnings estimate was $11.79 per share on revenue of $5.8 billion. Revenue grew 9,003.0% on a year-over-year basis. I'm long now because a P/E = 3.7 for a leading MRNA...
News - Better than expected Q4 EPS and sales results, the company expects to authorize a shares repurchase program up to 1.5B over the next two years. Levels -$195 is the next major resistance level. $138 is the next major support level. The stock is gapping up to $183 (pre-market). The idea is to go long at the open when it will try to test the $183 support...
BNTX has broken out nicely upon earnings it also aligns nicely with the pattern price is portraying which is an ascending scallop, commonly considered a bullish pattern
We just finished Elliot wave 1-5 and ABC pattern, already bounced off of a strong demand zone and 71.8% fib zone we can enter right now but our R/R ratio is 1.7 since we missed first bounce, what we are looking for is a retrace to our entry point ant 71.8% fib zone and enter there. Also market made a gap at 182 zone which has to be filled. Also a gap at 325 zone,...